GOSSAMER BIO, INC. Increase (Decrease) in Accrued Liabilities
GOSSAMER BIO, INC. (GOSS) reported Increase (Decrease) in Accrued Liabilities of -$1.40 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-13
- GOSSAMER BIO, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was -$1.16M.
- GOSSAMER BIO, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$234.00K, a 147.76% decline year-over-year.
- GOSSAMER BIO, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was -$223.00K.
- GOSSAMER BIO, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $1.31M.
- GOSSAMER BIO, INC. increase (decrease) in accrued liabilities for fiscal 2025 was $1.45M.
- GOSSAMER BIO, INC. increase (decrease) in accrued liabilities for fiscal 2024 was -$10.72M.
- GOSSAMER BIO, INC. increase (decrease) in accrued liabilities for fiscal 2023 was -$835.00K.
- GOSSAMER BIO, INC. increase (decrease) in accrued liabilities for fiscal 2022 was -$1.66M, a 325.41% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$1.40M 10-Q · filed 2026-08-13 | -$1.62M derived: sum of 3 quarters · filed 2026-08-13 | -$312.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | -$234.00K 10-Q · filed 2026-05-15 | -$457.00K derived: sum of 2 quarters · filed 2026-05-15 | $851.00K derived: sum of 3 quarters · filed 2026-05-15 | $724.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | -$223.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $1.08M derived: sum of 2 quarters · filed 2026-03-17 | $958.00K derived: sum of 3 quarters · filed 2026-08-13 | $1.45M 10-K · filed 2026-03-17 | |
| 2025-09-30 | $1.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.18M derived: sum of 2 quarters · filed 2026-08-13 | $1.67M 10-Q · filed 2025-11-05 | $731.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | -$127.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $363.00K 10-Q · filed 2026-08-13 | -$577.00K derived: sum of 3 quarters · filed 2026-08-13 | -$4.07M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | $490.00K 10-Q · filed 2026-05-15 | -$450.00K derived: sum of 2 quarters · filed 2026-05-15 | -$3.95M derived: sum of 3 quarters · filed 2026-05-15 | -$955.00K derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | -$940.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | -$4.44M derived: sum of 2 quarters · filed 2026-03-17 | -$1.45M derived: sum of 3 quarters · filed 2026-03-17 | -$10.72M 10-K · filed 2026-03-17 | |
| 2024-09-30 | -$3.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$505.00K derived: sum of 2 quarters · filed 2025-11-05 | -$9.78M 10-Q · filed 2025-11-05 | -$9.36M derived: sum of 4 quarters · filed 2026-03-17 | |
| 2024-06-30 | $2.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$6.28M 10-Q · filed 2025-08-05 | -$5.86M derived: sum of 3 quarters · filed 2026-03-17 | -$6.07M derived: sum of 4 quarters · filed 2026-03-17 | |
| 2024-03-31 | -$9.27M 10-Q · filed 2025-05-15 | -$8.85M derived: sum of 2 quarters · filed 2026-03-17 | -$9.06M derived: sum of 3 quarters · filed 2026-03-17 | -$9.84M derived: sum of 4 quarters · filed 2026-03-17 | |
| 2023-12-31 | $420.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $216.00K derived: sum of 2 quarters · filed 2026-03-17 | -$562.00K derived: sum of 3 quarters · filed 2026-03-17 | -$835.00K 10-K · filed 2026-03-17 | |
| 2023-09-30 | -$204.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$982.00K derived: sum of 2 quarters · filed 2024-11-07 | -$1.25M 10-Q · filed 2024-11-07 | -$1.35M derived: sum of 4 quarters · filed 2025-03-13 | |
| 2023-06-30 | -$778.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$1.05M 10-Q · filed 2024-08-12 | -$1.15M derived: sum of 3 quarters · filed 2025-03-13 | -$179.00K derived: sum of 4 quarters · filed 2025-03-13 | |
| 2023-03-31 | -$273.00K 10-Q · filed 2024-05-07 | -$371.00K derived: sum of 2 quarters · filed 2025-03-13 | $599.00K derived: sum of 3 quarters · filed 2025-03-13 | -$1.98M derived: sum of 4 quarters · filed 2025-03-13 | |
| 2022-12-31 | -$98.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $872.00K derived: sum of 2 quarters · filed 2025-03-13 | -$1.71M derived: sum of 3 quarters · filed 2025-03-13 | -$1.66M 10-K · filed 2025-03-13 | |
| 2022-09-30 | $970.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$1.61M derived: sum of 2 quarters · filed 2023-11-09 | -$1.56M 10-Q · filed 2023-11-09 | -$5.54M derived: sum of 4 quarters · filed 2024-03-05 | |
| 2022-06-30 | -$2.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$2.53M 10-Q · filed 2023-08-08 | -$6.51M derived: sum of 3 quarters · filed 2024-03-05 | -$1.45M derived: sum of 4 quarters · filed 2024-03-05 | |
| 2022-03-31 | $52.00K 10-Q · filed 2023-05-09 | -$3.93M derived: sum of 2 quarters · filed 2024-03-05 | $1.13M derived: sum of 3 quarters · filed 2024-03-05 | $1.52M derived: sum of 4 quarters · filed 2024-03-05 | |
| 2021-12-31 | -$3.98M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $1.08M derived: sum of 2 quarters · filed 2024-03-05 | $1.47M derived: sum of 3 quarters · filed 2024-03-05 | $736.00K 10-K · filed 2024-03-05 | |
| 2021-09-30 | $5.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $5.44M derived: sum of 2 quarters · filed 2022-11-03 | $4.71M 10-Q · filed 2022-11-03 | $3.04M derived: sum of 4 quarters · filed 2023-03-17 | |
| 2021-06-30 | $387.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$342.00K 10-Q · filed 2022-08-09 | -$2.01M derived: sum of 3 quarters · filed 2023-03-17 | $1.74M derived: sum of 4 quarters · filed 2023-03-17 | |
| 2021-03-31 | -$729.00K 10-Q · filed 2022-05-10 | $1.77M 10-Q · filed 2021-05-06 | -$2.40M derived: sum of 2 quarters · filed 2023-03-17 | $1.35M derived: sum of 3 quarters · filed 2023-03-17 | $2.61M derived: sum of 4 quarters · filed 2023-03-17 |
| 2020-12-31 | -$1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17 | $2.08M derived: sum of 2 quarters · filed 2023-03-17 | $3.33M derived: sum of 3 quarters · filed 2023-03-17 | $1.10M 10-K · filed 2023-03-17 | |
| 2020-09-30 | $3.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $5.01M derived: sum of 2 quarters · filed 2021-11-08 | $2.77M 10-Q · filed 2021-11-08 | $5.05M derived: sum of 4 quarters · filed 2022-03-03 | |
| 2020-06-30 | $1.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$982.00K 10-Q · filed 2021-08-09 | $1.30M derived: sum of 3 quarters · filed 2022-03-03 | $1.56M derived: sum of 4 quarters · filed 2022-03-03 | |
| 2020-03-31 | -$2.24M 10-Q · filed 2021-05-06 | $42.00K derived: sum of 2 quarters · filed 2022-03-03 | $300.00K derived: sum of 3 quarters · filed 2022-03-03 | $71.00K derived: sum of 4 quarters · filed 2022-03-03 | |
| 2019-12-31 | $2.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $2.54M derived: sum of 2 quarters · filed 2022-03-03 | $2.31M derived: sum of 3 quarters · filed 2022-03-03 | $1.52M 10-K · filed 2022-03-03 | |
| 2019-09-30 | $258.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $29.00K derived: sum of 2 quarters · filed 2020-11-10 | -$760.00K 10-Q · filed 2020-11-10 | $1.92M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2019-06-30 | -$229.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | -$1.02M 10-Q · filed 2020-08-11 | $1.66M derived: sum of 3 quarters · filed 2021-02-26 | $2.59M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2019-03-31 | -$789.00K 10-Q · filed 2020-05-12 | $1.89M derived: sum of 2 quarters · filed 2021-02-26 | $2.82M derived: sum of 3 quarters · filed 2021-02-26 | $4.71M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2018-12-31 | $2.67M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $3.61M derived: sum of 2 quarters · filed 2021-02-26 | $5.50M derived: sum of 3 quarters · filed 2021-02-26 | $5.94M 10-K · filed 2021-02-26 | |
| 2018-09-30 | $933.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $2.82M derived: sum of 2 quarters · filed 2019-11-12 | $3.26M 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $1.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $2.33M 10-Q · filed 2019-08-08 | |||
| 2018-03-31 | $441.00K 10-Q · filed 2019-05-14 | ||||
| 2017-12-31 | $824.00K 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 |